Clinical Trial Update: A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

View source ↗

Summary

This clinical trial update describes a post-marketing study evaluating intravenous Polymyxin B and Colistin Methanesulfonate for carbapenem-resistant Gram-negat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia Due to Gram-negative Bacteria
• Bacterial Pneumonia

Drugs mentioned

• Colistin methanesulfonate (colistin methanesulfonate)
• POLYMYXIN B (POLYMYXIN B SULFATE)

Snippet

Sponsor: TTY Biopharm | Conditions: Bacteremia Caused by Gram-Negative Bacteria, Bacterial Pneumonia | Status: RECRUITING